EcoDrugPlus

Ensembl ID : ENSIPUG00000013516
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSIPUG00000009169
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSIPUG00000010945
Gene Symbol: -
Cross references: -
140 Possible Orthologues:

Ensembl ID : ENSIPUG00000001374
Gene Symbol: -
Cross references: -
163 Possible Orthologues:

Ensembl ID : ENSIPUG00000024523
Gene Symbol: -
Cross references: -
215 Possible Orthologues:

Ensembl ID : ENSIPUG00000001020
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSIPUG00000001446
Gene Symbol: -
Cross references: -
97 Possible Orthologues:

Ensembl ID : ENSIPUG00000002848
Gene Symbol: -
Cross references: -
103 Possible Orthologues:

Ensembl ID : ENSIPUG00000012240
Gene Symbol: -
Cross references: -
112 Possible Orthologues:

Ensembl ID : ENSIPUG00000009144
Gene Symbol: -
Cross references: -
161 Possible Orthologues:

Ensembl ID : ENSIPUG00000004270
Gene Symbol: -
Cross references: -
4 Possible Orthologues:

Ensembl ID : ENSIPUG00000011840
Gene Symbol: -
Cross references: -
158 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).